Evidation

The research effort is a collaboration with nonprofit 4YouandMe, and will collect self-reported symptoms and wearables data from 300 high-risk participants.

Deborah Kilpatrick has spent some time on the cutting edge of the healthcare industry — her decade-spanning career has included a director position at Guidant Corporation’s vascular intervention accelerator (now part of Boston Scientific) and the chief commercial officer role at genomic diagnostic company CardioDx.

San Mateo, California-based health data analytics company Evidation Health announced today that it has raised $30 million in Series C funding.

Evidation Health just announced the launch of a 10,000 person chronic pain study, called the DisCover Project.